天津金耀信达

Tianjin Jinyao Xinda Pharmaceutical Technology is a specialized subsidiary of the Tianjin Jinyao Group, a leading Chinese pharmaceutical enterprise focused on hormone-based therapies. The company specializes in the research, development, and manufacturing of corticosteroid active pharmaceutical ingredients (APIs) and finished drug products. Its core portfolio includes essential glucocorticoids such as dexamethasone and prednisone, which are used to treat various inflammatory and autoimmune conditions. Jinyao Xinda operates state-of-the-art facilities that adhere to international GMP standards, supporting its role as a major supplier for both domestic and export markets. As part of the broader Tianjin Pharmaceutical Group, the company benefits from an integrated supply chain and extensive R&D resources. Its commitment to quality and innovation has established it as a key player in the global steroid medicine industry.